By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BTG plc 

10 Fleet Place
Limeburner Lane
London    EC4M 7SB  United Kingdom
Phone: 44-0-20-7575-0000 Fax: 44-0-20-7575-0010



Company News
BTG plc (BTG.L) Release: Vistogard And Voraxaze Added To Revised Guidelines For Stocking Of Antidotes In U.S. Hospitals 9/13/2017 9:50:46 AM
BTG plc (BTG.L) And SIO Expand Immuno-Oncology / Interventional Oncology Grant Programme 8/21/2017 6:36:38 AM
BTG plc (BTG.L) Release: ACCESS PTS Study Demonstrates Efficacy Of EKOS Therapy For Post-Thrombotic Syndrome 6/16/2017 6:32:28 AM
BTG plc (BTG.L) Release: New Study Shows Patients Treated With CroFab Have Improved Recovery From Copperhead Envenomation 6/13/2017 8:19:37 AM
BTG plc (BTG.L) Release: New Study Shows IO Loop Improves Patient Follow-Up, Engagement And Satisfaction Following Treatment With TheraSphere 6/12/2017 8:18:34 AM
BTG plc (BTG.L) Release: OPTALYSE PE Study Demonstrates Safety And Efficacy Of Shorter, Lower Dose EKOS Therapy For Pulmonary Embolism 5/22/2017 7:04:45 AM
BTG plc (BTG.L) Release: First European Patients Treated With Dc Bead Lumi Radiopaque Drug-Eluting Beads 4/20/2017 10:06:22 AM
BTG plc (BTG.L) Announces CE Mark Certification For DC Bead LUMI, The First Commercially Available Radiopaque Drug-Eluting Bead In The EU 3/7/2017 7:13:28 AM
BTG plc (BTG.L) Snags FDA Clearance for Blood Clot Device EKOS Control Unit 4.0 2/27/2017 7:23:20 AM
BTG plc (BTG.L) And Society Of Interventional Oncology To Explore Role Of Minimally Invasive Therapies In Immuno-oncology 2/15/2017 3:03:49 PM